Literature DB >> 396661

Pirenzepine in peptic ulcer. Introduction to clinical trials reports.

S M Chierichetti, M Gaetani, G Petrin.   

Abstract

The main pharmacodynamic characteristics of pirenzepine are briefly reported and the experimental plan of the clinical trial on pirenzepine in peptic ulcer is discussed.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 396661

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN： 0085-5928


  4 in total

1.  A placebo controlled comparison of the effects of pirenzepine and amitriptyline on the tyramine pressor test in healthy volunteers.

Authors:  M R Wilkins; R D Wynne; M J Kendall
Journal:  Br J Clin Pharmacol       Date:  1985-06       Impact factor: 4.335

2.  Role of prostaglandin E2 in cholinergic-mediated glycoprotein synthesis in canine antrum.

Authors:  K Yoshimura; E R Kraus; S Shimakura; J M Scheiman; C R Boland
Journal:  Dig Dis Sci       Date:  1992-07       Impact factor: 3.199

Review 3.  Pirenzepine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in peptic ulcer disease and other allied diseases.

Authors:  A A Carmine; R N Brogden
Journal:  Drugs       Date:  1985-08       Impact factor: 9.546

4.  Effect of transdermally administered hyoscine methobromide on nocturnal acid secretion in patients with duodenal ulcer.

Authors:  R P Walt; C J Kalman; R H Hunt; J J Misiewicz
Journal:  Br Med J (Clin Res Ed)       Date:  1982-06-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.